MAM Consortium

MAM Consortium is a non-profit industry-wide forum for Multi-Attribute Method (MAM) and other LC/MS applications in pharmaceutical and biotechnology companies for product characterization, in-process control, and GMP release and stability testing.

News

Impact story published by FDA: Transitioning a Powerful Analytical Tool into Manufacturing to Improve the Quality of Complex Therapeutics.

Events

Thursday May 16, 2019 from 9 am -10 am PDT

Presentation by John Schiel, NIST: Implementing the principles of MAM from NISTmAb to non-originators

Thursday July 25, 2019 from 9 am - 10 am PDT

Presentation by Da Ren, Amgen: Strategies and Practices for Implementing Multi-Attribute Method (MAM) in GMP Environment

Thursday August 22, 2019 from 9 am - 10 am PDT

Presentation by Ben Neely, NIST: QC Benchmarker: a streamlined web application to comprehensively evaluate instrument performance and direct troubleshooting

Tuesday October 22, 2019 from 9 am - 10 am PDT

Presentation by Sarah Rogstad, FDA: Quality Considerations for MAM

Tuesday November 19, 2019 from 9 am - 10 am PST

Presentation by Monica Sadek, Genentech: MAM Instrument Evaluation & Lessons Learned

Thursday December 5, 2019 from 8 am - 9 am PST

Presentation by Bo Zhai, Janssen R&D: Automated Sequence Variant Analysis and CLD Data Management

Friday April 3, 2020 from 8 am - 9 am PDT

Presentation by Michael Blank, AbbVie Inc.: Enabling Process Changes to Minimize Disulfide Scrambling Using a Non-Reducing Multi-Attribute Method

Friday June 19, 2020 from 8 am - 9 am PDT

Presentation by Zhiqi Hao, Genentech: Validation of MAM for QC Lab-of-the-Future

Friday July 31, 2020 from 8 am - 9 am PDT

Presentation by Yuko Ogata, Just – Evotec Biologics: Automated MAM Sample Preparation

Friday September 25, 2020 from 8 am - 9 am PDT

Presentation by Lucie Manache-Alberici & Cedric Mesmin, Merck Group: Validation of an LC-MS Multi-Attribute Method (MAM) Supporting Biopharma Process Characterization